68
6698G-eIFU-1016
•SpOCOHb
•SpOMetHb
•SpO
•SpO
•SpO
•
•
•Masimo
•
SIQ
SIQ(
X-Cal
(
•
•
500-NeoPt3-NeoPtM-LNCS, LNCS NeoPt, NeoPt-L
.The preferred site is the foot. Alternatively, across the palm and back of the hand can be used 1 kg > •
3-M-LNCS, LNCS Neo, Neo-L and Neo/
•.The preferred site is the foot. Alternatively, across the palm and back of the hand can be used 3 kg >
•. 40 <
3-M-LNCS, LNCS Inf, Inf-L and Inf
•.20-3
3-M-LNCS, LNCS Pdtx and Pdtx
•. 40
3-AdtxM-LNCS, LNCS Adtx
•. 40 <
(
. .1
(kg 3) 1kg >) and NEONATES >)
.500-NeoPt
.1 .2
...1 .3
.
.()
.()/.1 .4
./
..1 . .5
(20 - 3)
...2 . .2
.
.()/.2 .3
..2 .4
(kg 30 <) (kg 50 - 10)
3..3 .2
..
3..() 3 .3
.
.() .4
(
M-LNCS
. .4
LNCS
.
•
3-Neo Neo, Neo-L 3-Inf M-LNCS, LNCS Inf, Inf-L6 •
.
. •
.
3
6 •
.
. •
.:
M-LNCS
7
LNCS
..
.(EO) 3-InfInf, Inf-L ,500-NeoPt ,3-NeoPt, NeoPt-L, NeoPt ,3-Neo, Neo-L, Neo ,3-Pdtx, Pdtx ,3-M-LNCS, LNCS Adtx, Adtx
:. FDA-
54
40%
psia 1.3
30
54
40%
EO/750 - 600
()
Pdtx-3PdtxAdtx-3M-LNCS, LNCS Adtx 120
NeoP-500NeoPt-3NeoPt-L NeoPtNeo-3Neo, Neo-LInf-3M-LNCS, LNCS Inf, Inf-L 120
NeoPt-500NeoPt-3NeoPt-L NeoPtNeo-3Neo, Neo-LInf-3M-LNCS, LNCS Inf, Inf-L 180
()12
59 - 51
%70M-LNCS, LNCSMasimo SET
//(Std. Dev 1.) bpm 3 ± bpm 300-25(Std. Dev 1.)3 ±//(Std. Dev 1.) 2 SpO2 100
./
To Next Page
Loading...
Need help?
General
